329 related articles for article (PubMed ID: 25071820)
1. Using the zebrafish model for Alzheimer's disease research.
Newman M; Ebrahimie E; Lardelli M
Front Genet; 2014; 5():189. PubMed ID: 25071820
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish as a tool in Alzheimer's disease research.
Newman M; Verdile G; Martins RN; Lardelli M
Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease: amyloidogenesis, the presenilins and animal models.
Newman M; Musgrave IF; Lardelli M
Biochim Biophys Acta; 2007 Mar; 1772(3):285-97. PubMed ID: 17208417
[TBL] [Abstract][Full Text] [Related]
4. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
5. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity.
Moussavi Nik SH; Newman M; Wilson L; Ebrahimie E; Wells S; Musgrave I; Verdile G; Martins RN; Lardelli M
Hum Mol Genet; 2015 Jul; 24(13):3662-78. PubMed ID: 25814654
[TBL] [Abstract][Full Text] [Related]
7. Exploring Alzheimer's disease in zebrafish.
Xia W
J Alzheimers Dis; 2010; 20(4):981-90. PubMed ID: 20182049
[TBL] [Abstract][Full Text] [Related]
8. Presenilin mouse and zebrafish models for dementia: focus on neurogenesis.
van Tijn P; Kamphuis W; Marlatt MW; Hol EM; Lucassen PJ
Prog Neurobiol; 2011 Feb; 93(2):149-64. PubMed ID: 21056616
[TBL] [Abstract][Full Text] [Related]
9. Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ
Nery LR; Silva NE; Fonseca R; Vianna MRM
Neurochem Res; 2017 Oct; 42(10):2959-2967. PubMed ID: 28623607
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and Notch signaling.
Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG
Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579
[TBL] [Abstract][Full Text] [Related]
11. Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.
Duncan RS; Song B; Koulen P
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857474
[TBL] [Abstract][Full Text] [Related]
12. The BACE1-PSEN-AβPP regulatory axis has an ancient role in response to low oxygen/oxidative stress.
Moussavi Nik SH; Wilson L; Newman M; Croft K; Mori TA; Musgrave I; Lardelli M
J Alzheimers Dis; 2012; 28(3):515-30. PubMed ID: 22045484
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for Alzheimer's disease: how close are we?
Janus C
CNS Drugs; 2003; 17(7):457-74. PubMed ID: 12751917
[TBL] [Abstract][Full Text] [Related]
14. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease.
Chávez-Gutiérrez L; Szaruga M
Semin Cell Dev Biol; 2020 Sep; 105():75-85. PubMed ID: 32418657
[TBL] [Abstract][Full Text] [Related]
16. The development of an in vivo γ-secretase assay using zebrafish embryos.
Wilson L; Lardelli M
J Alzheimers Dis; 2013; 36(3):521-34. PubMed ID: 23666177
[TBL] [Abstract][Full Text] [Related]
17. Presenilins: how much more than γ-secretase?!
Coen K; Annaert W
Biochem Soc Trans; 2010 Dec; 38(6):1474-8. PubMed ID: 21118110
[TBL] [Abstract][Full Text] [Related]
18. Pathological and physiological functions of presenilins.
Vetrivel KS; Zhang YW; Xu H; Thinakaran G
Mol Neurodegener; 2006 Jun; 1():4. PubMed ID: 16930451
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G; Sernee MF; Masters CL
CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
[TBL] [Abstract][Full Text] [Related]
20. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
